Mechanistic description
In Alzheimer’s disease, SST interneurons in the entorhinal-hippocampal circuit gate gamma oscillations and synaptic plasticity. Analogously, in ALS, SST interneurons in the motor cortex regulate cortical excitability and oscillatory dynamics; modulating these cells via closed-loop focused ultrasound may restore pathological beta/gamma band desynchronization and reduce corticospinal hyperexcitability. This predicts that SST-targeted neuromodulation will improve motor performance and slow disease progression in ALS mouse models.
Analogy rationale: Both diseases involve cortical network dysfunction driven by interneuron impairment: AD shows hippocampal gamma fragmentation, while ALS exhibits motor cortex hyperexcitability and abnormal oscillations. SST interneurons are positioned to gate these cortical rhythms in both circuits, making them viable cross-disease targets for oscillatory restoration via mechanosensitive neuromodulation.
Disanalogies: AD primarily involves hippocampal-cortical circuits mediating memory, whereas ALS is a motor neuron disease with significant spinal cord and peripheral involvement. Additionally, motor cortex oscillations (beta band) differ mechanistically from hippocampal gamma oscillations, and the perforant path anatomy has no direct analog in the motor system. Ultrasound penetration to spinal motor neurons is also technically limited.
Falsifiable prediction: Closed-loop transcranial focused ultrasound targeting motor cortex SST interneurons in SOD1-G93A mice will (1) restore beta-band cortical oscillation power to wild-type levels, (2) reduce corticospinal excitability as measured by transcranial magnetic stimulation, and (3) extend survival by ≥10% compared to sham-treated controls.
This hypothesis was generated from h-var-b7e4505525 in Alzheimer's disease — judge it on its own merits but acknowledge the source.
Evidence for (3)
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis.
Identification of epilepsy-associated neuronal subtypes and gene expression underlying epileptogenesis.
A neural circuit for comorbid depressive symptoms in chronic pain.
Evidence against (2)
Somatostatin, Olfaction, and Neurodegeneration.
[(131)I]N-(6-amino-2,2,4-trimethylhexyl)-2-[(5-iodo(3-pyridyl))carbonylamino]-3-(2-napthyl)propanamide.